Suchergebnisse - "O'Connor, Owen A"

PubPharm (35)

1

A perspective on improving the R-CHOP regimen : from Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise

enthalten in: The Lancet. Haematology | 2020

von Lue, J. | O'Connor, O.

2

The peripheral T-cell lymphomas : an unusual path to cure

enthalten in: The Lancet. Haematology | 2020

von Ma, H. | Marchi, E. | O'Connor, O.

3

The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management

enthalten in: CA: a cancer journal for clinicians | 2020

von Marchi, E. | O'Connor, O.

4

A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder : efficacy of pralatrexate in primary refractory disease and review of the literature

enthalten in: Leukemia & lymphoma | 2019

von Ma, H. | Bhagat, G. | O'Connor, O.

5

New directions in treating peripheral T-cell lymphomas (PTCL) : leveraging epigenetic modifiers alone and in combination

enthalten in: Expert review of hematology | 2019

von Ma, H. | O'Connor, O. | Marchi, E.

6

Pralatrexate : a comprehensive update on pharmacology, clinical activity and strategies to optimize use

enthalten in: Leukemia & lymphoma | 2017

von O'Connor, O. | Amengual, J. | Colbourn, D. | +2

7

Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma

enthalten in: Hematology/oncology clinics of North America | 2017

von Marchi, E. | Raufi, A. | O'Connor, O.

8

Will new drugs change the standard of care for patients with mantle cell lymphoma?

enthalten in: Expert review of anticancer therapy | 2016

von Colbourn, D. | Amengual, J. | Deng, C. | +2

9

Emerging therapies in relapsed and refractory peripheral T-cell lymphoma

enthalten in: Clinical advances in hematology & oncology : H&O | 2015

von Bachow, S. | O'Connor, O.

10

Epigenetics and Lymphoma : Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?

enthalten in: Current oncology reports | 2015

von Lue, J. | Amengual, J. | O'Connor, O.